Silicon-Based Hydrogen Pills Reduce Asthma Symptoms in Mice
- Authors
- Honoka Takeuchi, Marumi Taya, Sana Takashima, Nobumasa Hino, Chihaya Kakinuma, Yuki Kobayashi, Hikaru Kobayashi, Shinsaku Nakagawa
- Journal
- Biomedical Journal
- Year
- 2026
- DOI
- 10.1016/j.bj.2026.101017
- Study Type
- Mouse
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- Japan
- Health Condition
- Allergic Bronchial Asthma
- Body System
- Respiratory
TL;DR
A dietary silicon-based hydrogen-generating agent reduced allergic airway inflammation in asthmatic mice, but the findings remain preclinical.
Key Finding
A silicon-based hydrogen-generating agent significantly reduced airway inflammation and immune cell infiltration in mice with allergic asthma, suggesting it may be an effective delivery method for hydrogen therapy.
Summary
Researchers tested a silicon-based material that generates hydrogen gas in the digestive system as a potential treatment for allergic asthma in mice. When mice with asthma-like symptoms received this material in their diet, it reduced the number of immune cells (eosinophils) in their airways, decreased inflammation in lung tissue, and lowered levels of inflammatory proteins and antibodies associated with allergic reactions.
Practical Takeaway
This early-stage mouse study suggests silicon-based hydrogen generators may help manage allergic asthma by reducing inflammation, but much more research is needed before any conclusions can be drawn for human use. The findings are limited to animal models and do not yet indicate whether this approach would be safe or effective in people with asthma.
Abstract (excerpt)
Background: Hydrogen therapy, which involves the intake of hydrogen as an antioxidant, has been reported to be effective against various oxidative stress-related diseases. However, current methods of hydrogen administration present various problems. Therefore, new methods that allow for the safe…